Transcarent

About Transcarent

Transcarent was founded in 2020 by Glen Tullman, the former CEO of Livongo (now part of Teladoc), with the ambitious goal of creating a single platform that consolidates the fragmented landscape of employer health benefits. The company offers everything from primary care and surgery navigation to pharmacy benefits and, increasingly, GLP-1 medication management as part of its Weight Health program. Transcarent is not a standalone telehealth weight loss clinic — it is an enterprise health benefits platform that happens to include one of the more comprehensive GLP-1 programs available through employer channels.

Patients access Transcarent through their employer’s benefits package, and costs are typically covered by the employer or health plan. The weight management program includes clinical evaluation, GLP-1 prescribing (brand-name medications), lab testing, registered dietitian consultations, and ongoing metabolic monitoring. What makes Transcarent distinctive is its integration of bariatric surgery navigation for patients who may benefit from surgical intervention — a holistic approach that acknowledges GLP-1s are not the right solution for every patient. The platform uses clinical algorithms to match patients with the most appropriate intervention based on their health profile.

Transcarent’s support level is high, with dedicated care navigators who help patients understand their options, coordinate with specialists, and manage the logistics of their treatment plan. The platform also integrates pharmacy benefits, which can simplify the often-frustrating process of getting GLP-1 prescriptions filled and covered by insurance. For patients whose employers offer Transcarent, this end-to-end coordination can eliminate many of the administrative headaches that plague GLP-1 access through traditional healthcare channels.

On Trustpilot, Transcarent holds a 2.9-star rating based on 2 reviews — a sample size too small to draw meaningful conclusions, but worth monitoring as the platform scales. The company’s C rating with the Better Business Bureau suggests some friction in complaint resolution, though as an employer-facing platform, Transcarent’s primary customer relationship is with HR departments rather than individual patients. Our editorial team notes that enterprise health platforms often receive lower consumer ratings because patients may not choose or fully understand the platform — it is assigned to them through their benefits.

Transcarent represents a next-generation approach to employer health benefits that happens to include excellent GLP-1 access. Its strengths are clinical breadth (medication, surgery, nutrition, navigation), employer-covered costs, and sophisticated care coordination. Its limitations are the same as other employer-gated platforms: if your company doesn’t offer it, you cannot access it independently. For employees with Transcarent benefits, the weight management program is a strong option that treats obesity as a multifaceted medical condition rather than a simple prescription need.

Transcarent GLP-1 Medications

At a Glance